Russia is expected to register a second potential vaccine against Covid-19 on Oct. 15, the vaccine's developer said on Friday.
The vaccine has been developed by Siberia's Vector Institute, which completed early-stage human trials of the vaccine last month.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)